TABLE 1

Clinical characteristics of subjects who underwent glucose clamp study

NonobeseObeseType 2 diabetesHypertension
n27144827
Age (years)31 ± 242 ± 348 ± 145 ± 2
Sex (M/F)14/136/821/2711/16
BMI (kg/m2)24 ± 139 ± 233 ± 131 ± 1
Fasting insulin (μU/ml)6.1 ± 0.815.9 ± 2.515.7 ± 2.510.8 ± 1.0
Fasting glucose (mg/dl)84 ± 289 ± 2161 ± 783 ± 2
Blood pressure (mmHg)121 ± 3/70 ± 1134 ± 3/76 ± 2130 ± 2/71 ± 1152 ± 3/88 ± 2
Total cholesterol (mg/dl)172 ± 7195 ± 9197 ± 5206 ± 8
LDL (mg/dl)89 ± 6112 ± 8124 ± 4142 ± 7
HDL (mg/dl)47 ± 342 ± 246 ± 154 ± 3
Triglycerides (mg/dl)128 ± 26146 ± 18183 ± 17139 ± 14
HbA1c (%)5.6 ± 0.16.0 ± 0.27.9 ± 0.25.7 ± 0.1
  • Data are means ± SE (n = 116). BMI: P < 2 ×10−6 for obese, diabetic, and hypertensive subjects, respectively, vs. normal nonobese subjects. Fasting insulin: P < 0.002 for obese, diabetic, and hypertensive subjects, respectively, vs. normal nonobese subjects. Total cholesterol: P < 0.03 for obese, diabetic, and hypertensive subjects, respectively, vs. normal nonobese subjects. LDL: P < 0.01 for obese, diabetic, and hypertensive subjects, respectively, vs. normal nonobese subjects.